Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 102051-102100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04355832
Glucagon-like Peptide-1 in Type 1 Diabetes
EARLY_PHASE1Recruiting
40 participants
Started: Jun 24, 2020 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04289870
Innoventric Trillium™ Stent Graft First-in-Human (FIH) Study
NAActive, not recruiting
20 participants
Started: Jun 24, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT04115163
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
PHASE2Recruiting
53 participants
Started: Jun 24, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04483284
Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients
PHASE2Active, not recruiting
28 participants
Started: Jun 24, 2020 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04305665
HIV Study on MEasuring the Reservoir on Cellular Level to CUre Infection
N/ARecruiting
25 participants
Started: Jun 24, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04645680
Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study
PHASE2Active, not recruiting
50 participants
Started: Jun 24, 2020 · Completed: Feb 28, 2026
6 conditions2 sponsors1 location
NCT03513003
The Use of a Pacifier to Correct Malocclusions in Young Children
NARecruiting
200 participants
Started: Jun 24, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04371224
NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer
PHASE2Recruiting
200 participants
Started: Jun 23, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT04451551
Myocardial Perfusion Imaging by 15O-H2O PET/CT
N/ARecruiting
5,000 participants
Started: Jun 23, 2020 · Completed: Aug 1, 2036
1 condition1 sponsor1 location
NCT04184973
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
NARecruiting
250 participants
Started: Jun 23, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor14 locations
NCT04550117
Intraspinal Pressure Monitoring for Acute Traumatic Spinal Cord Injury: A Validation Study
NARecruiting
20 participants
Started: Jun 23, 2020 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04115007
Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients
PHASE3Active, not recruiting
550 participants
Started: Jun 23, 2020 · Completed: Feb 28, 2031
1 condition1 sponsor35 locations
NCT04225039
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
PHASE2Active, not recruiting
39 participants
Started: Jun 23, 2020 · Completed: Apr 30, 2029
1 condition2 sponsors1 location
NCT03918421
Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study
N/ARecruiting
45 participants
Started: Jun 23, 2020 · Completed: Jun 23, 2030
1 condition1 sponsor2 locations
NCT06132321
Quality of Life in Patients Undergone Vulvar Reconstruction After Vulvar Cancer Resection (3233)
N/ARecruiting
93 participants
Started: Jun 23, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03203525
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
PHASE1Recruiting
52 participants
Started: Jun 23, 2020 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT04114266
Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD
N/AActive, not recruiting
180 participants
Started: Jun 23, 2020 · Completed: Apr 20, 2026
5 conditions2 sponsors19 locations
NCT03774654
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
PHASE1Active, not recruiting
13 participants
Started: Jun 22, 2020 · Completed: Feb 28, 2035
5 conditions4 sponsors2 locations
NCT04399876
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
PHASE1Enrolling by invitation
35 participants
Started: Jun 22, 2020 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location
NCT05670665
Impact of Threatened Preterm Labour in Fetal Cardiovascular and Metabolic Programming (SHs)
N/ARecruiting
200 participants
Started: Jun 22, 2020 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04428788
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1Active, not recruiting
250 participants
Started: Jun 22, 2020 · Completed: Dec 27, 2026
1 condition1 sponsor19 locations
NCT04454450
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer
NAActive, not recruiting
10 participants
Started: Jun 22, 2020 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06514300
Investigating Myosteatosis in Steatotic Liver Diseases
N/AEnrolling by invitation
100 participants
Started: Jun 22, 2020 · Completed: Aug 31, 2024
8 conditions3 sponsors1 location
NCT04393350
Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
PHASE2Active, not recruiting
18 participants
Started: Jun 22, 2020 · Completed: Jan 16, 2026
3 conditions3 sponsors1 location
NCT04322955
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
PHASE2Recruiting
48 participants
Started: Jun 22, 2020 · Completed: Feb 29, 2028
2 conditions3 sponsors4 locations
NCT04365868
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
PHASE2/PHASE3Active, not recruiting
357 participants
Started: Jun 22, 2020 · Completed: Sep 30, 2025
3 conditions1 sponsor156 locations
NCT04232553
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
PHASE3Active, not recruiting
778 participants
Started: Jun 22, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor322 locations
NCT04642508
The PreQ-20 TRIAL, a Prospective Cohort Study of Patients Undergoing Prepectoral Breast Reconstruction
NAActive, not recruiting
81 participants
Started: Jun 22, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04552275
The HALT Biomarker Study
PHASE1Recruiting
300 participants
Started: Jun 22, 2020 · Completed: Jun 22, 2035
3 conditions4 sponsors3 locations
NCT04443543
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
PHASE2Not yet recruiting
222 participants
Started: Jun 22, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04112186
Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction
NAActive, not recruiting
157 participants
Started: Jun 21, 2020 · Completed: Mar 31, 2031
1 condition3 sponsors1 location
NCT04400994
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
PHASE2Active, not recruiting
20 participants
Started: Jun 20, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04477889
Methodist Health System COVID-19 Patient Registry
N/ARecruiting
500 participants
Started: Jun 20, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04440670
Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates
PHASE3Recruiting
140 participants
Started: Jun 20, 2020 · Completed: Dec 31, 2023
1 condition14 sponsors2 locations
NCT06255054
Novel Approaches to Assessing Cannabis Impaired Driving (NAACID)
N/ARecruiting
130 participants
Started: Jun 20, 2020 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04456660
Comprehensive Assessment of Risks for Miscarriage.
N/ARecruiting
200 participants
Started: Jun 20, 2020 · Completed: Dec 1, 2023
1 condition1 sponsor1 location
NCT04374305
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
PHASE2Active, not recruiting
100 participants
Started: Jun 20, 2020 · Completed: Dec 1, 2030
5 conditions4 sponsors6 locations
NCT04547673
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
N/ARecruiting
1,000 participants
Started: Jun 20, 2020 · Completed: Dec 31, 2026
2 conditions2 sponsors3 locations
NCT04854317
Bariatric Endoscopy for Treatment of Obesity
NARecruiting
189 participants
Started: Jun 19, 2020 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT03914820
Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.
NARecruiting
330 participants
Started: Jun 19, 2020 · Completed: Jun 1, 2025
1 condition1 sponsor16 locations
NCT03997110
Palliative Radiation for Advanced Cervical Cancer
NARecruiting
230 participants
Started: Jun 19, 2020 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT04437511
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
PHASE3Active, not recruiting
1,736 participants
Started: Jun 19, 2020 · Completed: Nov 30, 2028
1 condition1 sponsor274 locations
NCT04792320
Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function
NARecruiting
180 participants
Started: Jun 19, 2020 · Completed: Apr 30, 2030
2 conditions1 sponsor1 location
NCT04028401
Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients
PHASE3Recruiting
110 participants
Started: Jun 19, 2020 · Completed: Jun 30, 2029
1 condition1 sponsor6 locations
NCT06145984
Mechanisms of Change of Positive Interventions in Reducing Vulnerability for Depression
NARecruiting
100 participants
Started: Jun 19, 2020 · Completed: Jan 1, 2024
1 condition3 sponsors1 location
NCT04263584
Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL
PHASE2Active, not recruiting
62 participants
Started: Jun 19, 2020 · Completed: Apr 30, 2025
1 condition2 sponsors12 locations
NCT04365179
Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML
PHASE1Recruiting
18 participants
Started: Jun 18, 2020 · Completed: Aug 30, 2025
2 conditions2 sponsors1 location
NCT05453604
Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications
NAActive, not recruiting
105 participants
Started: Jun 18, 2020 · Completed: Dec 31, 2023
4 conditions2 sponsors1 location
NCT04324580
Postoperative Immobilization and Physical Therapy Following Volar Locked Plating for Distal Radius Fractures
NAActive, not recruiting
230 participants
Started: Jun 18, 2020 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06514196
Post- Approval Hintermann Series H® Study 1
N/AActive, not recruiting
298 participants
Started: Jun 18, 2020 · Completed: Jan 20, 2025
3 conditions1 sponsor1 location